Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ORKAMBI

IVACAFTOR; LUMACAFTOR

Standard Dose
125MG;200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ORKAMBI is listed in Drugs@FDA under application 206038 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IVACAFTOR; LUMACAFTOR Form and strength TABLET;ORAL - 125MG;200MG Sponsor VERTEX PHARMS INC Submission history Latest submission status date: 2026-03-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORKAMBI is listed in Drugs@FDA under application 206038 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IVACAFTOR; LUMACAFTOR Form and strength TABLET;ORAL - 125MG;200MG Sponsor VERTEX PHARMS INC Submission history Latest submission status date: 2026-03-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ORKAMBI (IVACAFTOR; LUMACAFTOR) | Drug Monograph | MedicHelpline